ABSTRACT
Introduction
Infections with high-risk human papillomavirus (hr-HPV) are causative factors in the development of many benign and cancer diseases of skin and mucosa. High risk HPV have been detected in 99% biopsy samples of cervical carcinoma (15) . Cancer of the cervix is the second most common cancer in women worldwide (20) . For the laboratory diagnostics of premalignant lesions and cervical cancer the cytological test (Pap smear) is commonly used. However, the success of the Pap smear test is limited with respect to sensitivity and specificity (14) . Neither cytological test nor HPV DNA typing could indicate whether there will be a remission or progression to the invasive disease (2, 18) . This emphasises the need for specific cellular biomarkers to aid objective CIN lesion grading, and to identify true high-grade dysplasia of the cervix (4) .
It is known that the hr-HPV contributes to the neoplastic progression of infected cells predominantly through the action of two viral oncoproteins, E6 and E7. These proteins interact with various host regulatory proteins and influence the function or expression levels of host gene products, eventually leading to the disruption of the cell cycle (5) . E6 and E7 respectively degrade two key cellular negative regulatory proteins -p53 and retinoblastoma protein (pRb) (17, 19) . Due to the inactivation of pRb at the protein level, a specific cyclin-dependent kinase inhibitor, protein p16
INK4a , is released from negative feedback control. Normally, p16
INK4a decelerates the cell cycle by inactivating the cyclin-dependent kinase inhibitors, CDK4 and CDK6, which prevents complexing with cyclin D1, pRb phosphorylation, E2F liberation and induction of cell division. However, in the cases with inactivation of pRb by E7 the up-regulation of p16
INK4a occurs, resulting in paradoxically high levels of this tumour suppressor protein (1, 17 (13) .
In the curent study, we have investigated the expression of p16
INK4a at the mRNA level in a large number of cervical specimens by a quantitative reverse-transcriptase PCR and evaluated the correlation between the p16 INK4A mRNR expression level and the grade of cervical dysplasia and HPV genotypes.
Materials and Methods

Clinical specimens
Cervical specimens were collected at the Institute of Oncology, Vilnius University (Vilnius, Lithuania) by cytobrush. In total, 567 women with known histological and/or cytological diagnosis were included into the study. The study was approved by the Vilnius Regional Committee of Biomedical Research (Lithuania, permission No. 158200-6-062-16). All specimens were divided into three groups according to the cytological and histological diagnosis: the group of specimens with normal limits/cervicitis (n=151), the group of specimens with cervical dysplasia according to the cytological diagnosis (n=198) and the group of specimens with cervical dysplasia according to the histological diagnosis (n=218). The group of specimens with cytological diagnosis included 55 cases of atypical squamous cells of undetermined significance (ASCUS), 21 cases of low grade squamous intraepithelial lesion (LSIL) and 122 cases of high grade squamous intraepithelial lesion (HSIL). The group of specimens with histological diagnosis included 8 cases of CIN1 (cervical intraepithelial neoplasia grade 1), 11 cases of CIN2 (cervical intraepithelial neoplasia grade 2), 68 cases of CIN3/CIS (cervical intraepithelial neoplasia grade 3 or carcinoma in situ), 82 cases of cancer (Ca) and 49 patients with CIS treated by cervical conization (CIS/Con).
Extraction of RNA and DNA from clinical specimens and cDNA synthesis The extraction of RNA and DNA from clinical specimens was performed as previously described (3). The RNA extracted from the specimens was transcribed to copy DNA (cDNA) using Maxima expression level by quantitative PCR (qPCR) as described below. The DNA extracted from the same clinical specimens was used to determine HPV DNA and HPV types as described below.
HPV DNA detection and genotyping HPV DNA was amplified by wide-spectrum PCR using general primers GP5+/GP6+ and PGMY09/11 within the L1 open-reading frame (6, 8) . The quality of isolated DNA was tested using specific primers of β-globin gene and prostate specific antigen (PSA) gene. As a positive control, the DNA extracted from HeLa cells was used. The specimens positive for HPV DNA were genotyped by in-house developed multiplex PCR-based systems using four sets of specific primers for 16 HPV types: 16, 18, 39, 58, 31, 33, 52, 56, 59, 68, 35, 45, 66, 51, 73 and 82 (16) As a positive control for HPV genotyping, plasmids containing HPV DNA of the respective HPV type were used. The amplification products were analysed by electrophoresis in 2% agarose gels and visualized using ethidium bromide.
Development and optimization of quantitative RT-PCR
The qPCR was run using Maxima TM Probe/ROX qPCR Master Mix 2x (Thermo Scientific Fermentas). Three pairs of p16
INK4a specific primers were designed and tested: Inkrev-3 and Inkfor-3, Ink4for-1 and Ink4rev-1, Ink4for-2 and Ink4rev-2. The best results were obtained with Ink4for-2 and Ink4rev-2 primers. The amplified PCR product was of 147 bp in lenght. As an internal control, specific primers and probe for the integrin gene were used. Optimum concentrations of primers and probes as well as optimum annealing temperature was experimentally selected. Concentrations of primers and probes ranging from 0.15 to 0.4 μM and annealing temperatures ranging from 55.4 to 68.9°C were used. The qPCR was performed in a RotorGene 6000 (Qiagen, Germany). The optimum amplification conditions were 2 min at 50 o C, 7 min at 95°C, 95°C at 30 sec, 55°C at 20 sec, 72°C at 20 sec for a total of 40 cycles. INK4A expression, cDNA prepared from HPV-positive HeLa (ATCC NO. CCL-2) and CaSki (ATCC NO. CRL-1550) cell lines was used. As an internal control, cDNA of integrin gene fragment synthesized using specific primers was used. All reactions were run in duplicate. The number of calculated copies of the p16 ink4a gene were divided by a number of calculated copies of the internal control (integrin gene) and multiplied by the coefficient (x1000).
Quantitation of p16
Statistical analysis
Statistical analysis of experimental data was performed using the statistical software SPSS version 13.0. Data correlations were tested by using the Spearman's correlation coefficient. The Pearson χ 2 test was performed to compare the significance of the positive rates of high-risk HPV types and p16 
Results and Discussion
In total, 567 cervical cytological specimens collected from women with confirmed histological and/or cytological diagnosis were subjected to the study. In the first step, both DNA and RNA were isolated from clinical specimens. The isolated RNA was used to investigate the expression of p16
INK4a , whereas the isolated DNA was used to determine the positivity for HPV and HPV typing.
To develop and optimize qPCR for studying the expression of p16
INK4a at mRNA level, the recombinant plasmid pTZ57R with integrated p16
INK4a gene fragment was constructed and used to obtain RNR transcripts. The transcripts of the p16 INK4A target sequence were employed to design a standard curve for qPCR, which then was used as a reference standard for extrapolating quantitative information on p16 ink4a mRNR levels in clinical specimens (Fig. 1) . Selection of the house-keeping integrin gene as an internal control allowed standartization of the assay according to the quantity of cells and calculation of the copies of the p16 ink4a gene in each clinical specimen. The calculated number of p16
ink4a gene copies in 567 tested specimens varied from 599,558 to 49895,51. The correlation between p16 ink4a mRNA expression levels and the degree of cervical cytological/histological alterations was statistically evaluated. For studying the correlation between the p16 ink4a mRNA levels and cytological alterations, all specimens with known cytological diagnosis was divided into four subgroups: 151 cases of normal limits/cervicitis, 55 cases of ASCUS, 21 cases of LSIL and 122 cases of HSIL. As shown in For studying the correlation between the p16 ink4a mRNA levels and histological alterations, all specimens with known histological diagnosis were divided into seven subgroups: 151 cases of normal limits/cervicitis, 8 cases of CIN1, 11 cases of CIN2, 68 cases of CIN3/CIS, 82 cases of Ca and 49 cases of CIS/Con. As shown in Fig. 3 , the highest level of p16 INK4a mRNR was determined in CIN3/CIS specimens (mean 20182.76) and the lowest level in normal Pap smears (mean 599.56). Surprisingly, the expression level of p16 ink4a mRNA in specimens collected from patiens with cervical cancer was significantly lower than that in CIN3/CIS group (mean values 6882.50 and 20182.76, respectively). This suggests that the cellular processes leading to the up-regulation of p16
INK4a as a tumour suppressor protein may be disrupted during the phase of tumour progression (17) . INK4a protein in dysplastic squamous and glandular cells by immunocytochemical analysis (4, 7, 9, 10, 12) . On the other hand, our study demonstrated that expression levels of p16 ink4a mRNA (and consequently the levels of p16 ink4a at protein level) may decrease during tumour progression thus leading to the possible falsenegative results of the immunodetection.
As the disruption of the cell cycle leading to the oncogenic transformation of cervical cells is caused by hr-HPV infection, we have investigated the correlation between the p16 INK4A mRNR expression levels and the particular hr-HPV genotype. To determine the infectivity with HPV and identify hr-HPV types, we have used DNA isolated from 567 cervical cytological specimens.
To evaluate the relevance of DNA isolation from clinical specimens, the amplification of β-globin gene and PSA gene was performed using specific primers. Only 324 clinical specimens were found to be positive for either β-globin or PSA DNA that confirms the sufficient quality of the isolated DNA (data not shown). Therefore, 324 specimens out of 567 were further analysed for HPV DNA by two PCR-based systems: PGMY09/11 and GP5+/GP6+ (6, 8) . The numbers of HPV DNA-positive specimens detected by PGMY09/11 and GP5+/GP6+ primer systems were 175/324 (54%) and 230/324 (70.9%), respectively. In total, 275 specimens positive for HPV DNA were found. They were further analysed for HPV types by using a multiplex PCR system developed in-house (16) . The multiplex PCR system consisting of 4 sets of specific primers allowed detection of 16 hr-HPV types (HPV-16, -18, -39, -58, -31, -33, -52, -56, -59, -68, -35, -45, -66, -51, -73 and -82). Fifty-seven specimens out of 275 (21%) were positive for HPV-16. These data are in line with previous cohort studies indicating that HPV-16 is the most prevalent hr-HPV type (11, 21) . Two and more hr-HPV types were identified in 15 out of 275 specimens (5.4%). More than onehalf of the specimens (165/275) were negative for any of the tested hr-HPV types, which suggests that these specimens were infected with low-risk (nononcogenic) HPV types. The correlation between the particular hr-HPV genotype and the type of cytological and/or histological lesions was analysed. The majority of specimens with confirmed cervical cancer were positive for one or more hr-HPV types (data not shown). However, no evidences on the correlation between a particular hr-HPV genotype and the type of pathology were obtained. This indicates that all hr-HPV genotypes may cause pathology.
The results of hr-HPV genotyping were compared to the expression levels of p16 INK4a mRNR. It was determined that all hr-HPV types cause the increased p16
INK4a mRNA expression, however, the correlation between the particular hr-HPV type and the p16
INK4a mRNR level is obscure (Fig. 4) . This suggests that all hr-HPV types may dysregulate the cell cycle by a similar molecular mechanism. Therefore, it can be concluded that the oncogenic potential of HPV but not a particular hr-HPV type is the main cause of enhanced p16 
